




































































































































































































































































































































































































EFA's	implied	correlation	matrix	which	has	the	form	𝑃(𝜃) = 𝛬𝛹𝛬′ + 𝛥?.	
The	common	factor	model	represents	the	measured	variables	as	functions	of	latent	
(unobserved)	factors	as	well	as	model	parameters,	most	notably	factor	loadings.	In	matrix	
























































(K1),	which	is	based	on	𝑒,, 𝑒J, . . . 𝑒L—the	eigenvalues	of	the	observed	variable	correlation	
matrix.	K1	chooses	the	number	of	factors	to	be	equal	to	the	number	of	eigenvalues	greater	

























𝑙𝑜𝑔(ℒ) = − ,
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For	the	k	orthogonal-factor	model,	𝐴𝐼𝐶(𝑚) = −2×𝑙𝑜𝑔(ℒ(𝑚)) + [2𝑝(𝑚 + 1) − 𝑚(𝑚 −
1)]	(Akaike,	1987),	𝐵𝐼𝐶(𝑚) = −2×𝑙𝑜𝑔(ℒ(𝑚)) + log	(𝑛)[𝑝(𝑚 + 1) − 0.5𝑚(𝑚 − 1)]	(Lopes	&	



























































































rows	of	the	loading	matrix	𝛬	as	an	𝑚	dimensional	Dirichlet	vector	with	parameters	𝛼#,,, . . . 𝛼#,*	
we	can	generate	a	valid	loading	matrix	for	which	the	sum	of	squares	for	each	row	is	less	than	or	
equal	to	1	(avoiding	a	Heywood	case),	and	each	factor	matrix	entry	is	between	-1	and	1.	We	can	

















































































































































































































SSBIC	 BIC	 K1	 PA	 Trace	
100	 Strong	 100	 98	 100	 100	 79	
300	 Strong	 100	 99	 100	 100	 97	
500	 Strong	 100	 99	 100	 100	 99	
700	 Strong	 100	 98	 100	 100	 97	
1000	 Strong	 100	 98	 100	 100	 99	
100	 Moderate	 25	 0	 92	 99	 5	
300	 Moderate	 20	 0	 83	 100	 69	
500	 Moderate	 23	 0	 81	 100	 98	
700	 Moderate	 16	 0	 90	 99	 98	
1000	 Moderate	 24	 0	 86	 100	 100	
100	 Weak	 2	 0	 38	 75	 0	
300	 Weak	 0	 0	 34	 89	 30	
500	 Weak	 0	 0	 44	 79	 72	
700	 Weak	 1	 0	 40	 82	 89	
1000	 Weak	 0	 0	 33	 82	 97	
100	 Moderate,	low	dim	 0	 0	 0	 0	 5	
300	 Moderate,	low	dim	 0	 0	 0	 0	 8	
500	 Moderate,	low	dim	 0	 0	 0	 0	 19	
700	 Moderate,	low	dim	 0	 0	 0	 0	 13	
1000	 Moderate,	low	dim	 0	 0	 0	 0	 35	
100	 Moderate,	dif	dim	 0	 0	 16	 0	 2	
300	 Moderate,	dif	dim	 0	 0	 14	 0	 11	
500	 Moderate,	dif	dim	 0	 0	 11	 0	 41	
700	 Moderate,	dif	dim	 0	 0	 14	 0	 54	
1000	 Moderate,	dif	dim	 0	 0	 14	 0	 75	
100	 CRS	ibl	 100	 7	 100	 100	 61	
300	 CRS	ibl	 100	 5	 100	 100	 100	
500	 CRS	ibl	 100	 7	 100	 99	 100	
	
26	
700	 CRS	ibl	 100	 3	 100	 100	 100	
1000	 CRS	ibl	 100	 9	 100	 99	 100	
100	 CRS	i6m	 100	 0	 100	 99	 46	
300	 CRS	i6m	 100	 0	 100	 100	 94	
500	 CRS	i6m	 100	 0	 100	 98	 98	
700	 CRS	i6m	 100	 0	 100	 97	 95	
1000	 CRS	i6m	 100	 0	 100	 99	 97	
100	 CRS	i16m	 100	 0	 100	 95	 34	
300	 CRS	i16m	 100	 0	 100	 95	 96	
500	 CRS	i16m	 100	 0	 100	 91	 98	
700	 CRS	i16m	 100	 0	 100	 87	 96	
1000	 CRS	i16m	 100	 0	 100	 91	 99	
100	 10	factor	 100	 0	 100	 95	 34	
300	 10	factor	 100	 0	 100	 95	 96	
500	 10	factor	 100	 0	 100	 91	 98	
700	 10	factor	 100	 0	 100	 87	 96	










Method	 Baseline	 6-month	follow	up	 16-month	follow	up	
K1	 6	 5	 7	
PA	 5	 5	 6	
BIC	 15	 16	 14	
EBIC	 8	 8	 8	
SSBIC	 17	 17	 20	












































































































































𝜌 = 𝛬𝛹𝛬′ + 𝛥?	
where	𝛬	is	the	𝑝×𝑚	matrix	of	factor	loadings,	𝛹	is	the	(𝑚×𝑚)	factor	correlation	matrix,	and	
𝛥?	is	the	matrix	of	unique	variances	(𝑝×𝑝	diagonal	matrix).	
This	can	be	further	written	as	𝜌 = 𝛬𝛹𝛬′ + (𝐼 − diag(𝛬𝛹𝛬′))	
If	we	are	interested	in	generating	a	random,	structured	loadings	matrix,	the	following	









𝜌 = 𝛬𝛹𝛬′ + (𝐼 − diag(𝛬𝛹𝛬′))	


































































































































































































































































































































































































































































































































































































































































#	 Item	Label	 Factor	1	 Factor	2	 Factor	3	 Factor	4	 Factor	5	 Communalities	
1	 Blockage	 0.65	 	 	 	 	 0.80	
2	 Discharge	discolored	 0.49	 	 	 	 	 0.61	
3	 PND	 0.84	 	 	 	 	 0.78	
4	 Smell	loss	 	 	 	 0.95	 	 0.89	
5	 Facial	pain	 	 0.83	 	 	 	 0.85	
6	 Facial	pressure	 	 0.76	 	 	 	 0.87	
7	 Blockage	both	sides	 0.58	 	 	 	 	 0.72	
8	 Blockage	complete	 0.55	 	 	 	 	 0.73	
9	 Blockage	bothered	 0.61	 	 	 	 	 0.81	
10	 Discharge	a	lot	 0.86	 	 	 	 	 0.84	
11	 Blow	nose	10x	daily	 0.82	 	 	 	 	 0.76	
12	 Discharge	bothered	 0.84	 	 	 	 	 0.84	
13	 Cough	lie	down	 0.72	 	 	 	 	 0.73	
14	 Lump	in	throat	 0.69	 	 	 	 	 0.73	
15	 PND	bothered	 0.84	 	 	 	 	 0.85	
16	 Smell	loss	complete	 	 	 	 0.97	 	 0.95	
17	 Smell	loss	bothered	 	 	 	 0.92	 	 0.91	
18	 Facial	pain	5+	 	 0.83	 	 	 	 0.90	
19	 Facial	pain	bothered	 	 0.84	 	 	 	 0.91	
20	 Facial	pressure	severe	 	 0.77	 	 	 	 0.86	
21	 Facial	pressure	
bothered	
	 0.78	 	 	 	 0.90	
22	 Headaches	 	 0.67	 	 	 	 0.48	
23	 Fever	 	 	 0.43	 	 	 0.34	
24	 Coughing	 0.46	 	 0.5	 	 	 0.53	
25	 Bad	breath	 	 	 	 	 	 0.26	
26	 Fatigue	 	 	 	 	 	 0.39	
27	 Nasal	itching	 	 	 	 	 0.56	 0.53	
28	 Sneezing	 0.31	 	 	 	 0.54	 0.51	
29	 Eye	itching	 	 	 	 	 0.72	 0.62	
30	 Eye	tearing	 	 	 	 	 0.6	 0.49	
31	 Ear	fullness	 	 0.35	 	 	 0.54	 0.62	
32	 Ear	pain	 	 0.51	 	 	 0.49	 0.65	
33	 Ear	pressure	 	 0.47	 	 	 0.46	 0.63	
34	 Wheezing	 	 	 0.8	 	 	 0.66	
35	 Chest	tightness	 	 	 0.85	 	 	 0.78	
36	 Shortness	of	breath	 	 	 0.82	 	 	 0.68	
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#	 Item	Label	 Factor	1	 Factor	2	 Factor	3	 Factor	4	 Factor	5	 Communalities	
1	 Blockage	 0.46	 	 	 	 	 0.3	
2	 Discharge	discolored	 0.32	 	 	 	 	 0.19	
3	 PND	 0.49	 	 	 	 	 0.28	
4	 Smell	loss	 	 	 	 	 0.68	 0.47	
5	 Facial	pain	 	 0.66	 	 	 	 0.47	
6	 Facial	pressure	 	 0.59	 	 	 	 0.41	
7	 Blockage	both	sides	 0.43	 	 	 	 	 0.28	
8	 Blockage	complete	 0.34	 	 	 	 	 0.23	
9	 Blockage	bothered	 0.52	 	 	 	 	 0.4	
10	 Discharge	a	lot	 0.72	 	 	 	 	 0.5	
11	 Blow	nose	10x	daily	 0.66	 	 	 	 	 0.43	
12	 Discharge	bothered	 0.75	 	 	 	 	 0.54	
13	 Cough	lie	down	 0.34	 	 	 0.33	 	 0.29	
14	 Lump	in	throat	 0.36	 	 	 	 	 0.27	
15	 PND	bothered	 0.57	 	 	 	 	 0.4	
16	 Smell	loss	complete	 	 	 	 	 0.84	 0.69	
17	 Smell	loss	bothered	 	 	 	 	 0.68	 0.48	
18	 Facial	pain	5+	 	 0.78	 	 	 	 0.6	
19	 Facial	pain	bothered	 	 0.79	 	 	 	 0.63	
20	 Facial	pressure	severe	 	 0.65	 	 	 	 0.44	
21	 Facial	pressure	
bothered	
	 0.72	 	 	 	 0.54	
22	 Headaches	 	 	 	 	 	 0.14	
23	 Fever	 	 	 	 	 	 0.1	
24	 Coughing	 	 	 	 0.42	 	 0.29	
25	 Bad	breath	 	 	 	 	 	 0.12	
26	 Fatigue	 	 	 	 	 	 0.14	
27	 Nasal	itching	 	 	 0.35	 	 	 0.19	
28	 Sneezing	 	 	 0.38	 	 	 0.25	
29	 Eye	itching	 	 	 0.5	 	 	 0.29	
30	 Eye	tearing	 	 	 0.51	 	 	 0.3	
31	 Ear	fullness	 	 	 0.64	 	 	 0.41	
32	 Ear	pain	 	 	 0.53	 	 	 0.33	
33	 Ear	pressure	 	 	 0.63	 	 	 0.39	
34	 Wheezing	 	 	 	 0.58	 	 0.33	
35	 Chest	tightness	 	 	 	 0.64	 	 0.4	
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36	 Shortness	of	breath	 	 	 	 0.6	 	 0.37	




















































































#	 Item	Label	 Factor	1	 Factor	2	 Factor	3	 Factor	4	 Factor	5	 Communalities	
1	 Blockage	 0.51	 	   0.65 0.65	
2	 Discharge	discolored	 0.33	 	   0.46 0.46	
3	 PND	 0.76	 	   0.65 0.65	
4	 Smell	loss	 	   0.98	 0.9	 0.9	
5	 Facial	pain	 	 0.89	 	  0.84 0.84	
6	 Facial	pressure	 	 0.86	 	  0.85 0.85	
7	 Blockage	both	sides	 0.5	 	   0.61 0.61	
8	 Blockage	complete	 0.39	 	   0.53 0.53	
9	 Blockage	bothered	 0.6	 	   0.78 0.78	
10	 Discharge	a	lot	 0.87	 	   0.81 0.81	
11	 Blow	nose	10x	daily	 0.82	 	   0.7 0.7	
12	 Discharge	bothered	 0.85	 	    0.82	
13	 Cough	lie	down	 0.53	 	 0.34	 	  0.64	
14	 Lump	in	throat	 0.55	 	    0.64	
15	 PND	bothered	 0.79	 	    0.78	
16	 Smell	loss	complete	 	   0.97	 	 0.94	
17	 Smell	loss	bothered	 	   0.92	 	 0.89	
18	 Facial	pain	5+	 	 0.87	 	   0.88	
19	 Facial	pain	bothered	 	 0.89	 	   0.91	
20	 Facial	pressure	
severe	
	 0.83	 	   0.84	
21	 Facial	pressure	
bothered	
	 0.85	 	   0.88	
22	 Headaches	 	 0.61	 	   0.49	
23	 Fever	 	  0.39	 	  0.38	
24	 Coughing	 0.4	 	 0.5	 	  0.57	
25	 Bad	breath	 	     0.33	
26	 Fatigue	 	     0.43	
27	 Nasal	itching	 	    0.48	 0.51	
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28	 Sneezing	 0.37	 	   0.47	 0.53	
29	 Eye	itching	 	    0.68	 0.61	
30	 Eye	tearing	 	    0.6	 0.5	
31	 Ear	fullness	 	    0.71	 0.69	
32	 Ear	pain	 	 0.31	 	  0.64	 0.68	
33	 Ear	pressure	 	    0.66	 0.69	
34	 Wheezing	 	  0.81	 	  0.68	
35	 Chest	tightness	 	  0.87	 	  0.81	
36	 Shortness	of	breath	 	  0.87	 	  0.73	











#	 Item	Label	 Factor	1	 Factor	2	 Factor	3	 Factor	4	 Factor	5	 Communalities	
1	 Blockage	 0.34	 0.42	 	   0.63	
2	 Discharge	discolored	 	 0.3	 	   0.48	
3	 PND	 	 0.68	 	   0.64	
4	 Smell	loss	 	   0.98	 	 0.9	
5	 Facial	pain	 0.88	 	    0.86	
6	 Facial	pressure	 0.88	 	    0.86	
7	 Blockage	both	sides	 0.33	 0.34	 	   0.57	
8	 Blockage	complete	 0.34	 0.38	 	   0.57	
9	 Blockage	bothered	 0.4	 0.43	 	   0.72	
10	 Discharge	a	lot	 	 0.84	 	   0.78	
11	 Blow	nose	10x	daily	 	 0.81	 	   0.67	
12	 Discharge	bothered	 	 0.85	 	   0.8	
13	 Cough	lie	down	 	 0.38	 0.42	 	  0.57	
14	 Lump	in	throat	 	 0.38	 	   0.57	
15	 PND	bothered	 	 0.68	 	   0.72	
16	 Smell	loss	complete	 	   0.99	 	 0.94	
17	 Smell	loss	bothered	 	   0.93	 	 0.9	
18	 Facial	pain	5+	 0.92	 	    0.89	
19	 Facial	pain	bothered	 0.92	 	    0.89	
20	 Facial	pressure	
severe	
0.87	 	    0.81	
21	 Facial	pressure	
bothered	
0.89	 	    0.86	
22	 Headaches	 0.58	 	    0.49	
23	 Fever	 	  0.35	 	  0.35	
24	 Coughing	 	 0.34	 0.52	 	  0.6	
25	 Bad	breath	 	     0.35	
26	 Fatigue	 	  0.3	 	  0.45	
27	 Nasal	itching	 	    0.46	 0.56	
28	 Sneezing	 	 0.42	 	  0.44	 0.56	
29	 Eye	itching	 	    0.63	 0.61	
30	 Eye	tearing	 	    0.55	 0.52	
31	 Ear	fullness	 	    0.59	 0.68	
32	 Ear	pain	 0.41	 	   0.5	 0.68	
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33	 Ear	pressure	 0.34	 	   0.54	 0.68	
34	 Wheezing	 	  0.85	 	  0.69	
35	 Chest	tightness	 	  0.85	 	  0.75	
36	 Shortness	of	breath	 	  0.89	 	  0.72	










#	 Item	Label	 Factor	1	 Factor	2	 Factor	3	 Factor	4	 Factor	5	 Communalities	
1	 Blockage	 0.68	 	    0.49	
2	 Discharge	discolored	 0.43	 	    0.24	
3	 PND	 0.7	 	    0.45	
4	 Smell	loss	 	   0.63	 	 0.42	
5	 Facial	pain	 	 0.67	 	   0.51	
6	 Facial	pressure	 	 0.61	 	   0.51	
7	 Blockage	both	sides	 0.58	 	    0.39	
8	 Blockage	complete	 0.49	 	    0.34	
9	 Blockage	bothered	 0.58	 	    0.46	
10	 Discharge	a	lot	 0.79	 	    0.57	
11	 Blow	nose	10x	daily	 0.73	 	    0.52	
12	 Discharge	bothered	 0.75	 	    0.57	
13	 Cough	lie	down	 0.49	 	    0.34	
14	 Lump	in	throat	 0.52	 	    0.37	
15	 PND	bothered	 0.71	 	    0.55	
16	 Smell	loss	complete	 	   0.87	 	 0.75	
17	 Smell	loss	bothered	 	   0.71	 	 0.52	
18	 Facial	pain	5+	 	 0.79	 	   0.62	
19	 Facial	pain	bothered	 	 0.83	 	   0.68	
20	 Facial	pressure	
severe	
	 0.71	 	   0.49	
21	 Facial	pressure	
bothered	
	 0.79	 	   0.62	
22	 Headaches	 	     0.12	
23	 Fever	 	     0.09	
24	 Coughing	 	  0.48	 	  0.3	
25	 Bad	breath	 	     0.13	
26	 Fatigue	 	     0.14	
27	 Nasal	itching	 	     0.15	
28	 Sneezing	 	  0.31	 	  0.22	
29	 Eye	itching	 	     0.22	
30	 Eye	tearing	 	     0.21	
31	 Ear	fullness	 	    0.64	 0.43	
	
91	
32	 Ear	pain	 	    0.63	 0.41	
33	 Ear	pressure	 	    0.74	 0.53	
34	 Wheezing	 	  0.54	 	  0.3	
35	 Chest	tightness	 	  0.59	 	  0.34	
36	 Shortness	of	breath	 	  0.57	 	  0.33	











#	 Item	Label	 Baseline	–	6	month	follow	up	 6	-	16	month	follow	up	
1	 Blockage	 0.49	 0.3	
2	 Discharge	discolored	 0.24	 0.19	
3	 PND	 0.45	 0.28	
4	 Smell	loss	 0.42	 0.47	
5	 Facial	pain	 0.51	 0.47	
6	 Facial	pressure	 0.51	 0.41	
7	 Blockage	both	sides	 0.39	 0.28	
8	 Blockage	complete	 0.34	 0.23	
9	 Blockage	bothered	 0.46	 0.4	
10	 Discharge	a	lot	 0.57	 0.5	
11	 Blow	nose	10x	daily	 0.52	 0.43	
12	 Discharge	bothered	 0.57	 0.54	
13	 Cough	lie	down	 0.34	 0.29	
14	 Lump	in	throat	 0.37	 0.27	
15	 PND	bothered	 0.55	 0.4	
16	 Smell	loss	complete	 0.75	 0.69	
17	 Smell	loss	bothered	 0.52	 0.48	
18	 Facial	pain	5+	 0.62	 0.6	
19	 Facial	pain	bothered	 0.68	 0.63	





22	 Headaches	 0.12	 0.14	
23	 Fever	 0.09	 0.1	
24	 Coughing	 0.3	 0.29	
25	 Bad	breath	 0.13	 0.12	
26	 Fatigue	 0.14	 0.14	
27	 Nasal	itching	 0.15	 0.19	
28	 Sneezing	 0.22	 0.25	
29	 Eye	itching	 0.22	 0.29	
30	 Eye	tearing	 0.21	 0.3	
31	 Ear	fullness	 0.43	 0.41	
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32	 Ear	pain	 0.41	 0.33	
33	 Ear	pressure	 0.53	 0.39	
34	 Wheezing	 0.3	 0.33	
35	 Chest	tightness	 0.34	 0.4	
36	 Shortness	of	breath	 0.33	 0.37	
37	 Cold/flu	symptoms	 0.2	 0.24	
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Chapter	4	-	Conclusion	
	
There	are	many	uses	for,	and	methods	of,	conducting	EFA.	In	this	thesis,	I	have	
proposed	a	new	method	to	identify	the	number	of	factors	to	extract,	studied	its	performance	in	
application	to	certain	data	structures,	and	applied	EFA	model	selection	and	factor	extraction	
methods	to	estimate	latent	structure	in	symptoms	common	in	CRS	and	its	related	co-morbid	
conditions.		
The	proposed	method	for	determining	the	number	of	factors	to	extract	during	an	EFA	
adds	to	the	vast	literature	addressing	the	problem	of	estimating	𝑚	and	how	to	navigate	this	
situation.	This	new	𝑚-estimation	procedure	performed	well	under	a	variety	of	simulated	
testing	conditions	which	varied	with	regard	to	sample	size	(𝑁),	data	dimensionality	(𝑃),	and	
strength	of	correlation	structure.	Thus,	this	method	may	be	a	viable	and	versatile	option	of	
estimating	the	underlying	factor	model	when	sample	size	is	sufficiently	large.	
The	CRS	symptom	EFA	shed	light	on	the	studied	symptoms,	which	decomposed	into	five	
interpretable	factors,	generating	several	hypothesized	biological	factor	underpinnings.	We	
were	able	to	identify	congestion	and	discharge,	smell	loss,	ear	and	eye,	asthma	and	
constitutional,	and	facial	pain	and	pressure	symptom	factors.	These	factors	are	consistent	with	
understanding	of	biology	and	pathological	processes	in	individual	sinuses.	
Our	CRS	study	utilized	Cattell’s	scree	test	(5,	5,	and	5	factors)	and	parallel	analysis	(5,	5,	
and	6	factors)	in	order	to	determine	the	number	of	factors	to	extract	for	the	baseline,	6-month	
follow-up,	and	16-month	follow-up	questionnaires.	Interestingly,	these	methods	estimated	
modestly	different	𝑚	compared	with	the	Kaiser	eigenvalue	greater	than	1	rule	(K1;	6,	5,	and	7	
factors)	and	quite	different	m	compared	with	other	commonly	utilized	methods	including	the	
Bayesian	information	criterion	(BIC;	15,	16,	and	14	factors)	and	sample	size	adjusted	BIC	(SSBIC;	
17,	17,	and	20	factors),	for	baseline,	6-month,	and	16-month	follow-up	questionnaires,	
respectively.	Our	newly	proposed	trace	method	also	produced	an	optimal	factor	cardinality	far	
removed	from	those	presented	in	the	CRS	paper	(13,	13,	and	16	for	baseline,	6-month,	and	16-
month	questionnaires,	respectively).	In	Chapter	2	we	hypothesized	that	these	differences	may	
be	explained	by	differing	standards	of	fit	implicated	by	the	different	levels	of	specificity	
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(dimensionality	versus	distributional	form)	addressed	by	the	methods’	objective	criteria.	
Further	research	is	needed	to	elucidate	this	conjecture.			
Determining	which	method	to	utilize	for	𝑚-estimation	is	difficult	for	several	reasons.	
Firstly,	there	are	a	large	number	of	potential	options	for	estimating	the	number	of	factors	with	
potentially	different	theoretical	foundations	including	likelihood-based	methods,	eigenvalue-
based	methods,	graphical	methods,	and	cross-validated	or	bootstrap	methods.	Investigators	
must	first	consider	the	purpose	of	their	analysis	when	deciding	which	method	to	utilize.	If	
interpretability	or	conciseness	is	of	paramount	importance,	one	may	consider	methods	aligned	
with	this	ideal.	Otherwise,	for	example,	if	one	is	placing	emphasis	on	identifying	the	number	of	
factors	in	a	FA	model	hypothesized	to	literally	underlie	the	data,	methods	attuned	to	that	goal	
such	as	BIC	or	TRACE	should	be	considered.	This	target	determination	is	important,	as	it	will	
drive	the	results	and	inference	downstream	in	the	analysis.	This	thesis	has	shown	that	the	
choice	of	𝑚	can	substantively	impact	qualitative	and	quantitative	changes	in	loading	and	factor	
interpretations.	As	such,	this	choice	directly	influences	whether	the	researcher’s	desired	goal	is	
attained	with	respect	to	unbiased	estimation,	verisimilitude,	generalizability,	or	interpretability.	
The	results	are	thus	of	high	importance	to	researchers	conducting	EFAs.	
We	recommend	that	future	work	focus	on	the	decision	of	which	method(s)	to	use	when	
attempting	to	find	𝑚	in	EFA	settings.	The	best	process	of	choosing	which	method	of	estimating	
𝑚	may	very	well	be,	firstly	identifying	what	interpretation	of	𝑚	is	relevant	for	the	current	
study,	narrowing	the	field	of	potential	methods.	Following	this,	a	practitioner	will	likely	still	be	
faced	with	choosing	between	several	methods	which	may	perform	differently	in	application	to	
the	observed	data.	It	is	clear	from	the	simulation	study	that	under	certain,	possibly	identifiable	
conditions,	methods	may	outperform	or	underperform	compared	to	their	average	efficacy	
across	conditions.	Because	the	strength	of	correlations	and	sample	size	of	observed	data	were	
strong	drivers	of	the	efficacy	of	comparative	methods,	these	attributes	along	with	others	
should	shed	light	on	which	method	is	most	appropriate.	Thus,	it	might	be	that	observed	
correlation	matrix	attributes	could	be	utilized	within	a	single	analysis	to	determine	which	
methods	would	perform	best	and	future	work	in	this	area	also	would	be	valuable.	A	practitioner	
could	then	choose	between	methods	with	an	understanding	and	anticipation	of	which	methods	
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may	be	most	appropriate	for	their	specific	data	at	hand.	Finally,	agreement	between	methods	
may	prove	to	be	evidence	that	the	agreed	upon	𝑚	is	desirable	compared	to	other	possibilities.	
Simulation	studies	such	as	the	one	described	in	the	methods	portion	of	the	thesis	can	address	
these	questions	for	us,	by	testing	hypothesized	methods	against	a	known	truth	we	generate.		
This	thesis	was	able	to	identify	similar	latent	structure	and	factor	identity	in	three	CRS	
symptom	questionnaire	administrations,	as	well	as	the	changes	in	symptom	response	scores	
between	administrations.	These	EFAs	were	consistent	with	the	hypothesis	that	hypothesized	
biopathological	phenomena	underlay	the	observed	symptom	responses.	However,	objective	
sinus	inflammation	data	must	be	incorporated	in	order	to	adequately	assess	this	hypothesis.		
The	trace	method	showed	promise	as	a	viable	additional	method	for	EFA	model	
selection,	outperforming	many	commonly	utilized	methods	across	several	simulation	
conditions.	However,	in	the	diverse	range	of	fields	where	EFA	is	utilized,	the	simulated	
scenarios	were	small	in	scope,	as	the	number	of	factors	assessed	was	always	between	5	and	10,	
the	number	of	variables	utilized	was	between	11	and	100,	and	the	number	of	simulated	
samples	was	between	100	and	1000.	This	thesis	brings	to	light	alternative	approaches	to	EFA	
and	EFA	model	selection	that	we	hope	will	prove	useful	as	they	are	further	refined.		
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